Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

Disease-causing mutation edited out of human embryos

07 August 2017

By Charlotte Spicer

Appeared in BioNews 912

Scientists have published their study confirming they are the first to correct a disease-causing mutation in human embryos using genome editing.

The team used CRISPR to successfully correct a mutation causing the often-fatal heart condition, hypertrophic cardiomyopathy (HCM), with significantly improved efficiency and accuracy than previous efforts.

'Every generation on would carry this repair because we've removed the disease-causing gene variant from that family's lineage,' said senior author Professor Shoukhrat Mitalipov of the Oregon Health and Science University, Portland. 'By using this technique, it's possible to reduce the burden of this heritable disease on the family and eventually the human population.'

The scientists used sperm donated by a man carrying a mutation in the MYBPC3 gene, one of the most common causes of HCM. They mixed the sperm with the CRISPR reagents and injected it into eggs from 12 healthy females via intracytoplasmic sperm injection.

The researchers found that just over 70 percent of the 42 CRISPR-injected embryos were successfully edited and contained two normal copies of the MYBPC3 gene. Under normal circumstances, roughly half of the embryos would have the mutation. The gene-corrected embryos developed in a similar manner to control embryos, although they were never intended for implantation.

Interestingly, despite the team introducing a copy of the healthy version of the gene alongside the CRISPR components, they found that the embryos used the maternal copy of the gene as a template for repair instead.

'Our technology successfully repairs the disease-causing gene mutation by taking advantage of a DNA repair response unique to early embryos,' said co-author Dr Jun Wu, at the Salk Institute, California.

Importantly, the scientists used a short-lived version of CRISPR which prevented any further, unwanted editing – known as 'off-target' effects – in the embryos. Injecting CRISPR at the same time as the sperm, instead of shortly after the point of fertilisation when cells are beginning to divide, also meant they avoided previous problems of mosaicism in all but one embryo.

'There is still much to be done to establish the safety of the methods, therefore they should not be adopted clinically,' commented Professor Robin Lovell-Badge of the Francis Crick Institute, who was not involved in the study. He also pointed out that the technique would probably not be able to correct maternal mutations, or even to insert 'more sophisticated genetic alterations.'

'The possibility of producing designer babies, which is unjustified in any case, is now even further away,' he said.

The implantation of edited human embryos is currently illegal in the UK. The HFEA said that high quality public discussion about the ethics of new treatments, expert scientific advice and a robust regulatory system would be crucial if genome editing were to be considered as a new treatment. '[Genome editing] would need to offer new options to couples at risk of having a child with a genetic disease, beyond current treatments like embryo testing,' they said.

Co-author Professor Juan Carlos Izpisua Belmonte of the Salk Institute agreed that scientists will need to proceed with caution as genome editing is still in its infancy.

'Thanks to advances in stem cell technologies and genome editing, we are finally starting to address disease-causing mutations that impact potentially millions of people,' he concluded.

The study was published in the journal Nature.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

02 October 2017 - by Dr Rachel Brown 
A genome editing technique called 'base editing' has been used to correct the mutation causing the inherited blood disorder beta-thalassemia in human embryos...
25 September 2017 - by Paul Waldron 
UK scientists have successfully edited the genome of human embryos to study the role of a gene key to the earliest stages of development...
04 September 2017 - by Annabel Slater 
A group of scientists have challenged the landmark study which reported the first successful editing of human embryos for a genetic disease...
04 September 2017 - by Eleanor Taylor 
As a scientist working in a fertility clinic, my normal everyday work routine is occasionally punctuated by the ripple effect that occurs when reports of a new groundbreaking reproductive technology enters the public consciousness. I am soon inundated with questions...
21 August 2017 - by Dr Rachel Huddart 
A new survey suggests that Americans are becoming more accepting of the use of genome editing in humans, and there is strong support for more public involvement in discussions on the technology...

31 July 2017 - by Charlotte Spicer 
Scientists in the US may have successfully used genome editing in human embryos to correct disease mutations, according to a report by MIT Technology Review...
13 March 2017 - by Dr Katie Howe 
Chinese scientists have successfully used genome editing to correct mutations in viable human embryos for the first time...
14 November 2016 - by Sarah Gregory 
Researchers have had further success using the CRISPR/Cas9 genome-editing technique to repair the mutation that causes sickle-cell anaemia...
26 September 2016 - by Anneesa Amjad 
A scientist in Sweden has become the first to edit genes in healthy human embryos...
11 April 2016 - by Ayala Ochert 
A second team in China report that they have created genetically modified human embryos, in an attempt to make them resistant to HIV, using the genome-editing technique CRISPR/Cas9...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation